- Home
- MRVI vs ACB Comparison
MRVI vs ACB Comparison
Compare MRVI & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- ACB
- Stock Information
- Founded
- MRVI 2014
- ACB 2013
- Country
- MRVI United States
- ACB Canada
- Employees
- MRVI N/A
- ACB N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- MRVI Health Care
- ACB Health Care
- Exchange
- MRVI Nasdaq
- ACB Nasdaq
- Market Cap
- MRVI 312.4M
- ACB 256.5M
- IPO Year
- MRVI 2020
- ACB N/A
- Fundamental
- Price
- MRVI $2.20
- ACB $4.48
- Analyst Decision
- MRVI Hold
- ACB
- Analyst Count
- MRVI 10
- ACB 0
- Target Price
- MRVI $6.84
- ACB N/A
- AVG Volume (30 Days)
- MRVI 1.5M
- ACB 943.6K
- Earning Date
- MRVI 08-11-2025
- ACB 08-06-2025
- Dividend Yield
- MRVI N/A
- ACB N/A
- EPS Growth
- MRVI N/A
- ACB N/A
- EPS
- MRVI N/A
- ACB N/A
- Revenue
- MRVI $241,856,000.00
- ACB $262,403,032.00
- Revenue This Year
- MRVI N/A
- ACB $11.13
- Revenue Next Year
- MRVI $10.70
- ACB $5.39
- P/E Ratio
- MRVI N/A
- ACB N/A
- Revenue Growth
- MRVI N/A
- ACB 28.58
- 52 Week Low
- MRVI $1.67
- ACB $3.42
- 52 Week High
- MRVI $9.95
- ACB $7.20
- Technical
- Relative Strength Index (RSI)
- MRVI 42.78
- ACB 47.14
- Support Level
- MRVI $1.99
- ACB $4.14
- Resistance Level
- MRVI $2.40
- ACB $4.65
- Average True Range (ATR)
- MRVI 0.16
- ACB 0.23
- MACD
- MRVI -0.06
- ACB -0.02
- Stochastic Oscillator
- MRVI 25.15
- ACB 35.42
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.